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INTRODUCTION
Plants are very useful to mankind. Many of them are used 
exclusively for medicinal purposes. According to the World 
Health Organization (WHO), “a medicinal plant is a plant 
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which, in one or more of its organs, contains substances that 
can be used for therapeutic purposes, or which are precursors 
for chemo‑pharmaceutical semi‑synthesis.” Such plants are in 
great demand by pharmaceutical companies for their active 
ingredients.[1,2]
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ABSTRACT
Glycosmis pentaphylla, Tridax procumbens, and Mangifera indica are well‑known plants available throughout India and they are commonly 
used for the treatment of various diseases including diabetes mellitus. The antidiabetic activity of the individual plant parts is well known, 
but the synergistic or combined effects are unclear. The concept of polyherbalism has been highlighted in Sharangdhar Samhita, an 
Ayurvedic literature dating back to 1300 AD. Polyherbal formulations enhance the therapeutic action and reduce the concentrations of 
single herbs, thereby reducing adverse events. The aim of the present study is to formulate a polyherbal formulation and evaluate its 
antidiabetic potential in animals. The polyherbal formulation was formulated using the ethanol extracts of the stem bark of G. pentaphylla, 
whole plant of T. procumbens, and leaves of M. indica. The polyherbal formulation contains the ethanol extracts of G. pentaphylla, 
T. procumbens, and M. indica in the ratio of 2:2:1. The quality of the finished product was evaluated as per the World Health Organization’s 
guidelines for the quality control of herbal materials. The quality testing parameters of the polyherbal formulation were within the limits. 
Fingerprint analysis of the polyherbal formulation showed effective separation at 366 nm, and it revealed that the active compound present 
in the polyherbal formulation and the active compounds present in all the three extracts were the same. The acute toxicity studies of the 
polyherbal formulation did not show any toxic symptoms in doses up to 2000 mg/kg over 14 days. The oral antidiabetic activity of the 
polyherbal formulation (250 and 500 mg/kg) was screened against streptozotocin (50 mg/kg; i.p.) + nicotinamide (120 mg/kg; i.p.) induced 
diabetes mellitus in rats. The investigational drug was administered for 21 consecutive days, and the effect of the polyherbal formulation 
on blood glucose levels was studied at regular intervals. At the end of the study, the blood samples were collected from all the animals for 
biochemical estimation, and the animals were sacrificed and the liver and pancreatic tissues were collected for histopathologic analysis. 
Polyherbal formulation showed significant antidiabetic activity at 250 and 500 mg/kg, respectively, and this effect was comparable with 
that of glibenclamide. The antidiabetic activity of polyherbal formulation is supported by biochemical and histopathologic analysis.
Key words: Glycosmis pentaphylla, High Performance Thin Layer Chromatography fingerprint analysis, Mangifera indica, 
Polyherbal formulation, Tridax procumbens
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Diabetes mellitus is one of the most common disorders af‑
fecting almost 6% of the world population and the dynamics of 
the diabetes are changing rapidly in low‑ to middle‑income coun‑
tries.[3] According to International Diabetes Federation’s (IDF) 
estimates, 80% of the world diabetic population will be from 
low‑ and middle‑income countries in 2030. As per IDF 2011 
report, China, India, and the United States of America have a 
diabetic population of 90.0, 61.3, and 23.7 million, which may 
be increased up to 129.7, 101.2, and 29.3 million, respectively, in 
2030.[4] Globally, diabetes is one of the six major causes of death 
and also causing various systemic complications. Diabetes mel‑
litus is treated by hormone therapy (insulin) or by administering 
glucose‑lowering agents such as alpha‑glucosidase inhibitors, 
sulfonylureas, biguanides, and thiazolidinediones. Development 
of an adverse event is one of the complications in the treatment of 
any systemic disorder; hence, many of the research institutes and 
pharmaceutical companies are involved in drug development to 
find the molecules with good therapeutic potential and less adverse 
events.[5] In the USA, 10‑25% of patients experience an adverse 
drug reaction and these adverse drug reactions are responsible for 
3.4‑7.0% of hospital admissions.[6]
In traditional systems of medicine, many plants have been 
documented to be useful for the treatment of various systemic 
disorders. Many of the traditional/indigenous systems of medi‑
cine are effective than the modern system of medicine, but they 
suffer from lack of complete standardization which is one of the 
important challenges faced by the traditional system of medicine. 
The concept of polyhedral formulation is well documented in the 
ancient literature. Compared to the single herb, the polyherbal 
formulation has better and extended therapeutic potential. Hence, 
the present study was planned to formulate and standardize a 
polyherbal formulation using a plant having known antidiabetic 
activity and evaluate its therapeutic effects in rodents.
MATERIALS AND METHODS
Collection of the plant
Taxonomically identified stem bark of Glycosmis pentaphyl‑
la (Rutaceae), whole plant of Tridax procumbens (Asteraceae), 
and leaves of Mangifera indica (Anacardiaceae) were collected 
from the Alagar kovil region, Madurai district. The collected 
plants were authenticated at the Department of Botany, American 
college, Madurai, Tamil Nadu. The voucher specimen of the plant 
was deposited in the Department of Pharmacology, Ultra College 
of Pharmacy, Madurai, India for further reference.
Animals
Adult Wistar rats (180 ± 10 g) of either sex were obtained 
from Sainath Enterprises, Hyderabad, India. The animals were 
housed in large, spacious polyacrylic cages at an ambient room 
temperature with 12‑h light/12‑h dark cycle. Rats had free access 
to water and rodent pellets diet (Hindustan Lever Ltd, Bangalore, 
India). The study was approved by the Institute Animal Ethics 
Committee of the Ultra College of Pharmacy and all the animal 
experiments were carried out according to the Committee for the 
Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA) guidelines, Ministry of Environment and Forests, 
Government of India.
Preparation of ethanolic extract of G. pentaphylla, 
T. procumbens, and M. indica plants
The shadow‑, air‑dried stem bark of G. pentaphylla, whole 
plant of T. procumbens, and leaves of M. indica were powdered 
and extracted with 80% absolute ethanol using Soxhlet apparatus 
for 6 h. The extracts were evaporated to dryness (resinous mate‑
rial) under reduced pressure at 60°C and stored at 4°C until use.
Phytochemical analysis
 One gram of each of the ethanolic extracts of G. pentaphylla, 
T. procumbens and M. indica was dissolved in 100 ml of its own 
mother solvent to obtain a stock of concentration 1% w/v and tested 
for the presence of carbohydrates, proteins, sterols, alkaloids, tan‑
nins, glycosides, flavonoids, phenolic compounds, and saponins.[7]
Preparation of polyherbal formulation
The polyherbal formulation (capsules) contained the ethanolic 
extracts of G. pentaphylla, T. procumbens, and M. indica in the 
ratio of 2:2:1. The quality of the polyherbal formulation was tested 
as per the WHO guidelines for the quality control of herbal materi‑
als.[8] As per the guidelines, specific tests such as sampling, ash 
content, extractable matter, foaming index, loss on drying, tannin 
content, foreign matters, and specific powder characteristic tests 
such as angle of repose and bulk density were undertaken and 
significant results were recorded.
Preparation of formulation by wet granulation method
The formulation preparation began with trials by adding a 
different ratio of binders and selecting the quantity of lubricants 
and preservatives, and finally the procedure was optimized. 
G. pentaphylla, T. procumbens, and M. indica extracts were finely 
powdered (sieve 40), and mixed in the ratio of 2:2:1 and taken for 
the preparation of capsules by wet granulation technique using 20% 
lactose solution as a binder. The wet mass was passed through sieve 
number 22 to obtain granules. The granules were dried at 45°C in 
a tray dryer. The granules were lubricated with 1% magnesium 
stearate. Diluents and preservatives were added. The optimized 
formulation showed very good flow properties. After this, the gran‑
ules from the optimized batch (20% lactose) were filled in capsules 
colored yellow‑red of size “0”  in a capsule filling machine. The 
capsules were then deducted and transferred into poly bags, labeled, 
and the samples were evaluated as per the testing requirements. 
Each 750 mg of herbal capsule contained the extracts of G. pen‑
taphylla (100 mg), T. procumbens (100 mg), M. indica (50 mg), 
and lactose and excipients – quantity sufficient (q.s.).
Preformulation studies
Preformulation parameters such as bulk density, tap density, 
Carr’s index, Hausner’s ratio, and angle of repose were determined 
for the laboratory granules.[9,10]
Standardization of formulation
Physicochemical parameters of raw materials were determined 
as per the guidelines of the WHO, which includes moisture content, 
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total ash value, water‑soluble ash, acid‑insoluble ash, heavy 
metals, water‑soluble extractive, alcohol‑soluble extractive, and 
acidity (pH).[11‑13]
pH value: pH of 1% solution was determined by using a digital 
pH meter.
Ash value and extractive value: Total ash, water soluble ash, 
acid soluble ash and extractive values were determined as the 
procedure described elsewhere.[11‑12]
Limit test for heavy metals: Qualitative estimation of heavy 
metals was done for the detection of arsenic and lead as per the 
Ayurvedic pharmacopoeial procedures.
Capsule evaluation: The polyherbal capsules were evaluated 
for their description, microbial load, uniformity of dosage units, 
weight variation, disintegration time, and moisture content, and 
compared with Indian pharmacopoeial standards.
Microbial load analysis: For the safe use of the polyherbal 
capsules, microbial count was done and it was checked whether 
the total aerobic viable count, yeasts and molds were within the 
prescribed limits and the microorganisms, Escherichia coli, Clos‑
tridia, Salmonellae, Shigella, Pseudomonas, and Staphylococcus, 
were absent in the final formulation.
Weight variation: Twenty capsules were individually weighed 
and the average weight of the capsule was calculated. The indi‑
vidual weights of the each capsule should be within the limits of 
90% and 110% of the average weight.
Moisture content: Moisture content was determined by using 
automatic Karl Fischer titration apparatus.
Disintegration time: Disintegration test was performed us‑
ing the digital microprocessor based disintegration test appara‑
tus (Electro lab, Mumbai, India). One capsule was introduced 
into each tube and a disk was added to each tube. The assembly 
was suspended in water in a 1000 ml beaker. The volume of water 
at its highest point was at least 25 mm below the surface of the 
water and at its lowest point was at least 25 mm above the bot‑
tom of the beaker. The apparatus was operated and maintained at 
a temperature of 37 ± 2°C.
High‑performance thin layer chromatography (HPTLC) fin‑
gerprint analysis: Randomly few capsules were selected. They 
were opened and the contents were collected. The capsule content 
was dissolved in a minimum volume of mobile phase and used 
for the fingerprint analysis. Twenty milligram either individual 
herbal extract or polyherbal formulation was reconstituted in 1 ml 
of ethanol and filtered through a 0.45 μm membrane filter. The 
filtrate was used for the HPTLC analysis. The butanol:glacial acetic 
acid:water in the ratio 4:1:1, and toluene:ethyl acetate:methanol 
in the ratio 7:2:1 was used as mobile phase for the development 
of chromatogram. The chromatogram developed using mobile 
phase consisting of toluene:ethyl acetate:methanol (7:2:1) has 
showed good separation.
 Linomat IV automated TLC applicator CAMAG (Switzer‑
land), densitometer–CAMAG TLC scanner 3, and CAMAG CATS 
4 software were used for fingerprint analysis. A 2 µl sample (8 mm 
band) was spotted (Track 1: G. pentaphylla, Track 2: M. indica, 
Track 3: T. procumbens, and Track 4: Polyherbal formulation) and 
the chromatogram was developed in 20 × 10 cm twin trough glass 
chamber saturated with toluene: ethyl acetate: methanol (7:2:1) 
solvent system. The plates were exposed to the mobile phase for 
20 min and the air‑dried plates were viewed in Ultraviolet light to 
mid‑day light. The chromatograms were scanned by densitometer 
at 254, 366, and 520 nm. The Rf values, peak areas, and fingerprint 
data were recorded by winCATS 1.4.3 software. The Rf values 
were calculated using the formula: “distance traveled by the solute 
from the origin/distance traveled by the solvent from the origin.”
Development of quality control standards for the polyherbal 
capsule
The physiochemical (moisture content, limit test for heavy 
metals, monographic analysis of plant material, pH, and disinte‑
gration time) and microbial load analyses were performed for the 
herbal capsules to ensure the content uniformity and quality.[12]
Acute oral toxicity
Acute oral toxicity of the polyherbal formulation was carried 
out as per the guidelines set by the Organization for Economic 
Co‑operation and Development (OECD), revised draft guidelines 
423. The principle involves a stepwise procedure with the use of a 
minimum number of animals per step to obtain sufficient information 
on the acute toxicity of the test substance to enable its classification. 
Healthy Wistar rats (3 animals/dose) of either sex were used for the 
experiment. Overnight fasted rats were orally fed with the plant 
extracts and polyherbal formulation in increasing dose levels of 5, 
50, 300, and 2000 mg/kg body weight, respectively. The animals 
were observed for their behavioral (alertness, restlessness, irritabil‑
ity, and fearfulness), neurological (spontaneous activity, reactivity, 
touch response, pain response, and gait), and autonomic (defecation 
and urination) profiles continuously for 24 h. After a period of 24 h, 
the animals were observed for 14 days for mortality.[14]
Antidiabetic effect of herbal formulation in streptozotocin‑ 
and nicotimanide‑induced diabetic rats
The male Wistar rats were divided into five different groups 
of six animals each as follows.
Group I: Normal control
Group II: Diabetic control
 Group III: Diabetic rats treated with polyherbal prepara‑
tion (250 mg/kg)
 Group IV: Diabetic rats treated with polyherbal prepara‑
tion (500 mg/kg)
Group V: Diabetic rats treated with glibenclamide (0.25 mg/kg).
Diabetes was induced in overnight‑fasted rats by adminis‑
tering single intraperitoneal (i.p.) injection of freshly prepared 
streptozotocin (STZ) 50 mg/kg b.w. followed by 120 mg/kg of 
nicotimanide (NIC) in 0.1 M citrate buffer (pH 4.5) in a volume 
of 0.5 ml/kg b.wt.[15] Diabetes was confirmed in the STZ + NIC 
treated rats by measuring fasting blood glucose levels after 48 h 
of induction. After 24 h of STZ + NIC injection, the rats were 
given 5% w/v of glucose solution (2 ml/kg b.w.) to prevent hypo‑
glycemic mortality. Rats with fasting blood glucose of more than 
200 mg/dl were considered as diabetics and they were divided 
randomly into four different groups. The standard (glibenclamide) 
and herbal formulation were suspended in 1% w/v carboxymethyl 
cellulose (CMC) and administered once daily through oral gavage 
for 21 consecutive days. The blood samples were collected on 1st, 
Petchi, et al. / Journal of Traditional and Complementary Medicine 4 (2014) 108‑117
111
7th, 14th, and 21st days of the treatment, through the tail vein of 
rats by pricking and were immediately used for the estimation of 
blood glucose with a glucometer. Weekly body weight variations 
were monitored for all the experimental animals.
At the end of the experiment, the blood sample was withdrawn 
from all the experimental animals through retro‑orbital plexus 
puncture/posterior vena cava in plain and sodium ethylenediamine‑
tetraacetic acid (EDTA) tubes for biochemical analysis.[16] Finally 
the animals were sacrificed by diethyl ether anesthesia, and liver 
and pancreatic tissues were excised and used for biochemical and 
pathological analysis. Part of the tissue sample was preserved in 
an ice‑cold container for biochemical analysis and the remaining 
was stored in 10% formalin solution for histopathologic analysis.
Biochemical analysis
The whole blood sample was used for the estimation of glu‑
cose (One‑Touch Horizon glucometer; Ortho‑Clinical Diagnostics, 
Johnson and Johnson Company, USA), hemoglobin, and glycosyl‑
ated hemoglobin (HbA1c). The plasma sample was used for the 
estimation of insulin (radioimmunoassay kit; Diasorin, Italy). The 
serum was used for the estimation of biochemical markers such as 
creatinine, urea, protein, liver glycogen, total serum cholesterol, 
serum triglyceride, high density lipoprotein (HDL)‑cholesterol, 
serum glutamate oxaloacetate transaminase (SGOT), and serum 
glutamate pyruvate transaminase (SGPT). The biochemical 
markers were measured using a Prietest Easylab ‑ Biochemistry 
Analyser (Robonik [India] Private Limited) and the LAB‑KITS 
enzymatic kits. The liver tissue homogenate was used for the 
estimation of protein and glycogen.
Estimation of glucose: A drop of the whole blood sample was 
used for measuring glucose using One‑Touch H orizon glucometer, 
with gluco strips.
Estimation of hemoglobin: Hemoglobin in the blood was es‑
timated by the method of Drabkin and Austin (1932). To 0.02 ml 
of blood, 5.0 ml of Drabkin’s reagent was added, mixed well, and 
allowed to stand for 10 min. The solution was read at 540 nm 
together with the standard.[17]
Estimation of HbA1c: Erythrocytes were washed with normal 
saline, lysed with 5 ml of water, and incubated at 37°C for 15 min. 
The contents were centrifuged, the supernatant was discarded, and 
0.5 ml of saline was added. To 2 ml of aliquot, 4 ml of oxalate 
hydrochloride solution was added and the contents were heated at 
100°C for 4 h, cooled, and precipitated with 2 ml of 40% trichlo‑
roacetic acid (TCA). The mixture was centrifuged, and to 0.5 ml 
of supernatant, 0.5 ml of 80% phenol and 3 ml of concentrated 
sulfuric acid were added. The developed color was read at 480 nm 
after 30 min.
Working standards (10‑50 μg) were prepared using 1% fructose 
solution. Then, 0.5 ml of 80% phenol and 3 ml of concentrated 
sulfuric acid were added to the working standards and read at 
480 nm after 30 min. The concentration of HbA1c was expressed 
as mg/g of hemoglobin.
Estimation of protein: The liver tissue was homogenized 
in 20 mM Tris‑HCl and used for the estimation of protein. To 
0.5 ml of tissue homogenate, 0.5 ml of 10% TCA was added and 
centrifuged for 10 min. The precipitate was dissolved in 1.0 ml 
of 0.1 N NaOH.  To this, an aliquot of 4.5 ml of alkaline copper 
reagent was added and allowed to stand at room temperature for 
10 min. To this reaction mixture, 0.5 ml of Folin’s phenol reagent 
was added and the blue color developed was read after 20 min 
at 640 nm. A standard curve was obtained with standard bovine 
albumin and was used to assay the tissue protein level of enzyme 
activity. Values were expressed as mg/g of tissue.[18]
Estimation of liver glycogen: The alkali extract of the tissue 
was prepared by digesting 50 mg of fresh tissue with 3 ml of 30% 
potassium hydroxide solution in a boiling water bath for 15 min. 
The tubes were cooled and a drop of 1 M ammonium acetate was 
added to precipitate glycogen and kept in a freezer overnight for 
complete precipitation. Glycogen was collected by centrifuging at 
300 rpm for 20 min. Then the precipitate was dissolved by heating 
and again the glycogen was re‑precipitated by adding alcohol and 
1 M ammonium acetate and centrifuged. The final precipitate was 
dissolved in saturated ammonium chloride solution by heating 
in a boiling water bath for 5 min. Aliquots of glycogen solution 
were taken up for suitable dilution and 4 ml of anthrone reagent 
was added by cooling the tubes in an ice bath. The tubes were 
shaken well, covered with marble caps, and heated in a boiling 
water bath for 20 min. After cooling, the absorbance was read 
at 640 nm against water blank treated in a similar manner. The 
standard glucose solution was also treated similarly. The glyco‑
gen content was calculated from the amount of glucose present 
in the sample by multiplying with the factor 0.91, and expressed 
as mg/100 g of tissue.
Histopathologic analysis
Part of the liver and pancreas tissue were preserved in 10% 
formalin for 2 days. The liver and pancreas were dehydrated with 
alcohol (subsequently with 70, 80, 90%, and absolute alcohol) 
for 12 h each. Again the tissues were cleaned by using xylene 
for 15‑20 min and they were subjected to paraffin infiltration in 
automatic tissue processing unit. The tissue blocks were prepared 
and the blocks were cut using microtome to get sections of thickness 
5 µm. The sections were taken on a microscopic slide on which 
egg albumin (sticky substance) was applied and allowed for dry‑
ing. Finally, the sections were stained with eosin (acidic stain) and 
hemotoxylin (basic stain).
Statistical analysis
All the data were expressed as mean ± SEM. Statistical sig‑
nificance between the groups were tested using one‑way analysis 
of variance (ANOVA) followed by Dunnett’s t‑test post‑hoc test. 
A P less than 0.5 was considered significant.
RESULTS
Photochemical analysis
The yield of ethanolic extracts of G. pentaphylla, T. procum‑
bens, and M. indica was 25.6%, 20.6%, and 5.34% w/w (dry weight 
basis), respectively. The phytochemical analysis of the ethanolic 
extract of G. pentaphylla showed the presence of alkaloids, tannins, 
flavonoids, and saponins, of T. procumbens showed the presence 
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of alkaloids, flavonoids, saponins, and phenolic compounds, and 
of M. indica showed the presence of alkaloids, tannins, flavonoids, 
and phenolic compounds.
Preformulation studies
Preformulation parameters such as bulk density, tap density, 
Carr’s index, Hausner’s ratio, and angle of repose were obtained 
for the laboratory granules. The granules showed excellent flow 
property. The results are presented in Table 1.
Development of quality control standards for polyherbal 
capsule
Final batch samples of polyherbal capsules were analyzed for 
its organoleptic characters, physico chemical parameters, limits for 
heavy metals and microbial load [Table 2]. The study on capsules 
revealed that they were uniform in content and weight. Further, 
the moisture content, microbial load, limit test for heavy metals, 
monographic analysis of plant material, pH, and disintegration 
time were calculated and these values were found to be within 
normal limits.
Fingerprint analysis of polyherbal formulation
Fingerprint analysis at 366 nm showed good and effective 
compound separation than the analysis at 254 and 520 nm. The 
obtained Rf values and peak areas in densitometry TLC Scan‑
ner 3 at 366 nm are shown in Table 3. The fingerprint of 3D 
display at 366 nm and in densitometry is shown in Figure 1, 
and visualization comparison spots of all the three extracts 
with polyherbal formulation at 254, 366, and 520 nm are 
shown in Figure 2. The fingerprint reports of all the four tracks 
revealed that the active compound present in the polyherbal 
formulation and the active compounds present in all the three 
extracts were the same.
The same Rf values and peak areas were obtained in the formu‑
lation when compared with the individual Rf values and peak areas 
of herbal drugs. This shows that the marker compound present in 
individual herbals extracts and the marker compounds present in 
the formulation are the same. The visualization comparison spots 
of all the three extracts with polyherbal formulation at 366 nm 
are shown in Figure 3.
Toxicity study of polyherbal formulation
Acute toxicity studies did not show any mortality up to 
2000 mg/kg given as single oral administration. Hence, the study 
was carried out at the dose levels of 250 and 500 mg/kg.
Antidiabetic activity of the polyherbal formulation
Throughout the study, the diabetic animals showed significant 
reduction in body weight when compared to the control animals. 
However, the polyherbal formulation and glibenclamide inhibited 
the diabetes‑induced body weight reduction [Figure 4].
Diabetic control animals showed severe hyperglycemia com‑
pared to normal animals. The mean blood glucose level in the 
diabetic control group on day 0 was 248.63 ± 2.11 mg/dl and on 
day 21 was 328.92 ± 1.20 mg/dl. It was observed that the standard 
drug glibenclamide lowered the blood glucose level significantly, 
bringing it back to near normal level, whereas the polyherbal 
capsule at 250 mg/kg and 500 mg/kg significantly (P < 0.001) 
decreased the fasting blood serum glucose level in the diabetic 
rats on 7th, 14th, and 21st days, as compared to the diabetic control 
group. The results are presented in Table 4.
Diabetic animals showed significant decrease in plasma insu‑
lin, hemoglobin, and HbA1c levels when compared with control 
animals. Herbal formulation and glibenclamide reversed the 
insulin depletion in diabetic condition and also brought back the 
hemoglobin and HbA1c levels to normal [Table 5].
Diabetic animals showed significant reduction in liver glyco‑
gen and total protein levels when compared to the control animals, 
whereas herbal formulation and glibenclamide treated animals 
showed normal liver glycogen and total protein levels. The pre‑
vention of depletion of glycogen in the liver tissue was possibly 
due to stimulation of insulin release from the β cells that activates 
the glycogen synthase system. Effects of herbal formulation and 
Table 1. Preformulation studies and results of flow properties
Parameters Results
Bulk density 0.721 g/ml
Tapped density 0.693 g/ml
Carr’s index 4.04%
Hausner’s ratio 1.14±0.05
Angle of repose 19.03°
Table 2. Standardization of polyherbal capsule
Name of the test Observations
Organoleptic characters
Description Brown color powder 
filled in yellow cap/red 
body, 0 size capsule
Color Brown color powder
Odor Characteristic
Taste Bitter
Physicochemical parameters
pH 7.8
Moisture content 1.02%
Average weight 506 mg
Weight variation 490‑520 mg
Disintegration time (Mean ± SEM) 3 min 20 sec±0.25
Loss on drying 2.54%
Total ash 5.67%
Acid‑insoluble ash 1.24%
Water‑soluble ash 3.47%
Water‑soluble extractive value 15.36%
Ethanol‑soluble extractive value 13.41%
Limits for heavy metals
Arsenic not more than 5 ppm Complies
Lead not more than 10 ppm Complies
Microbial load analysis
Total microbial count NMT 1000 cfu/g 112 cfu/g
Yeasts and molds Nil
Presence of E. coli (should be absent) Absent
Presence of Salmonella (should be absent) Absent
Presence of Streptococcus (should be absent) Absent
Presence of Pseudomonas (should be absent) Absent
NMT: Not‑more‑than
Petchi, et al. / Journal of Traditional and Complementary Medicine 4 (2014) 108‑117
113
glibenclamide on the liver and renal markers of diabetic animals 
are presented in Table 6.
The diabetic rats showed significant (P < 0.001) increase in 
serum lipid profiles except HDL when compared to the control 
animals, whereas the levels in the treatment group remained within 
normal limits at the end of the study. Effects of herbal formula‑
tion and glibenclamide on the lipid profile of diabetic animals are 
presented in Table 7.
Histopathology results
The histopathologic analysis of pancreas revealed severe 
congestion, huge decrease in the number of islets of Langerhans 
and β cells, and fibrosis and inflammatory cell infiltration into the 
islets of Langerhans in STZ‑ and NIC‑induced hyperglycemic 
rats. While the polyherbal formulation at the dose of 250 mg/kg 
and 500 mg/kg showed mild congestion and mild decrease in the 
number of islets of Langerhans with normal β cell population, 
indicating significant amount of recovery. Glibenclamide treat‑
ment showed moderate congestion with moderate decrease in the 
number of islets of Langerhans and β cells and mild lymphocytic 
infiltration [Figure 5].
Histopathology of the liver [Figure 6] in normal control ani‑
mals showed normal hepatic cells with well‑preserved cytoplasm, 
nucleus, nucleolus, and central vein. In diabetic control animals, 
the liver sections showed that the lobular architecture was main‑
tained, but there was also a severe fatty change, sinusoidal dilation 
and congestion, mild portal inflammation, fibrosis, severe feathery 
degeneration, and necrosis. Diabetic rats treated with herbal for‑
mulation showed hepatocytes with nearly normal appearance and 
minimal necrosis. The sections of glibenclamide treated animals 
showed normal hepatic cells and no abnormality.
DISCUSSION
The polyherbal formulation was formulated using the etha‑
nolic extracts of the stem bark of G. pentaphylla, whole plant of 
T. procumbens, and leaves of M. Indica, which are mixed properly 
in 2:2:1 ratio. The antidiabetic activity of the individual plants has 
been proven. The stem bark of G. pentaphylla showed significant 
antidiabetic and antiarthritic activities against STZ‑induced diabe‑
tes and Freund’s complete adjuvant induced arthritis, respectively, 
in rats at the dose levels of 400 and 800 mg/kg.[19] The 50% ethanol 
extract of the leaves of M. indica showed a significant hypogly‑
Table 3. Rf values and peak areas at 366 nm
Rf value Area (AU)
Track Track
1 2 3 4 1 2 3 4
0.07 0.12 0.04 0.05 574.6 3136.3 1112.1 419.3
0.20 0.21 0.10 0.12 2317.9 2301.3 1993.3 2200.1
0.29 0.26 0.23 0.26 1896.9 2449.1 2121.9 4677.6
0.35 0.30 0.39 0.42 6592.0 3593.3 1094.2 9406.1
0.38 0.37 0.44 0.55 4356.8 10314.4 1724.0 3038.7
0.42 0.51 0.69 0.70 3167.0 3088.6 1529.8 2693.0
0.45 0.68 0.82 0.85 1483.2 2192.6 556.0 8306.6
0.53 0.84 0.98 0.92 4302.7 1584.4 276.9 937.2
0.72 0.91 0.98 2365.4 3290.3 10342.7
0.84 0.98 11882.4 1856.5
0.91 602.0
0.98 6654.1
Track 1: Glycosmis pentaphylla; Track 2: Mangifera indica; Track 3: Tridax 
procumbens; Track 4: Polyherbal formulation
Figure 1. Fingerprinting of 3D display at 366 nm in densitometry detection (pink color: Glycosmis pentaphylla, blue color: Mangifera indica, green 
color: Tridax procumbens, brown color: polyherbal formulation)
Figure 2. Visualization comparison spots of all the three extracts with 
polyherbal formulation (GP: Glycosmis pentaphylla, MI: Mangifera 
indica, TP: Tridax procumbens, PHF: polyherbal formulation)
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cemic effect against STZ‑induced diabetes in rats at a dose of 
250 mg/kg.[20] In humans, the aqueous and alcoholic extracts of 
the leaves of M. indica showed a significant hypoglycemic effect 
at a dose level of 1 g/kg/d.[21] Methanolic extract of the whole plant 
of T. procumbens showed significant antidiabetic activity against 
alloxan‑induced diabetes in rats at 250 and 500 mg/kg b.wt.[22] 
In some studies, the leaves of T. procumbens showed significant 
antidiabetic potential in rodents.[23]
In the modern era, herbal formulations have gained greater 
importance than ever before, mainly due to their efficacy and 
easy availability,[24] as well as less side effects as compared to the 
synthetic drugs.[25]  These advantages have led the people move 
toward herbal preparations, for disease treatment and preven‑
tion, as they are claimed to display synergistic, potentiative, and 
agonistic/antagonistic actions and the mixture of species in them 
shows better therapeutic effect than either species on its own.[26] 
The concept of polyherbalism has been highlighted in Sharangdhar 
Samhita, an Ayurvedic literature dating back to 1300 AD.[27] Poly‑
Table 4. The effect of polyherbal formulation on fasting blood glucose levels (mg/dl) in STZ‑and NIC‑induced diabetic rats
Treatment Blood glucose level in mg/dl
0th day 7th day 14th day 21st day
Vehicle‑normal control 90.2±0.60 94.18±1.34 92.14±1.27 91.31±1.10
Diabetic control 248.63±2.11 280.11±2.24 315.19±0.73 328.92±1.20
PHF 250 mg/kg 244.67±1.57*** 200.6±3.38*** 150.50±1.69*** 121.10±1.94***
PHF 500 mg/kg 242.24±2.66*** 193.2±2.04*** 142.21±1.91*** 117.20±2.12***
Glibenclamide 0.25 mg/kg 240.23±2.14*** 180.73±2.87*** 130.73±2.01*** 112.41±2.96***
PHF: Polyherbal formulation. Values are expressed as mean±SEM (n=6). ***P<0.001 compared to diabetic control (one‑way ANOVA followed by a 
Dunnett’s t test) STZ: Streptozotocin; NIC: Nicotimanide
Figure 3. The chromatograms of all the four tracks at 366 nm (Track 1: Glycosmis pentaphylla, Track 2: Mangifera indica, Track 3: Tridax procumbens, 
Track 4: polyherbal formulation)
Petchi, et al. / Journal of Traditional and Complementary Medicine 4 (2014) 108‑117
115
herbal formulations enhance the therapeutic action and reduce the 
concentrations of single herbs, thereby reducing the adverse events.
The HPTLC analysis of polyherbal formulation was carried 
out at the wavelengths of 254, 366, and 520 nm. The quality 
control system for the herbal preparation differs from the al‑
lopathic system of medicine. Polyherbal formulation comprises 
hundreds of unique or species‑specific compounds and it is 
difficult to completely characterize these compounds. When 
formulating a polyhedral formulation, there are chances for 
chemical interaction and loss of a particular bioactive com‑
pound.[28] In the present study, single herbs, viz., G. pentaphylla, 
T. procumbens, M. indica, in the radio of 2:2:1 showed clear 
compound separation.
The toxicity studies were carried out as per the OECD guide‑
lines. The polyherbal formulation did not show any mortality or 
adverse event up to 2000 mg/kg. Hence, the study was carried out 
at the dose levels of 250 and 500 mg/kg.
STZ is toxic glycoside obtained from Streptomyces achromo‑
genes, a gram‑positive bacterium. It accumulates in pancreatic 
β cells via the glucose transporter 2 (GLUT2) and reduces their 
expression. The alkylating properties of the STZ modify the bio‑
logical macromolecules, fragment DNA, and destroy the β cells, 
causing insulin‑dependent diabetes.[29] In the diabetic control 
group, severe body weight loss was observed, which may be due 
to increased muscle wasting and loss of tissue proteins.[30] In the 
present study, the treatment groups showed significant improve‑
ment in body weight, which indicates that polyherbal formulation 
Table 5. Effect of polyherbal formulation on plasma insulin level in STZ‑and NIC‑induced diabetic rats
Treatment Plasma insulin level (μIU/ml) Hb (mg/dl) HbA1C (mg/g of Hb%)
0th day 7th day 14th day 21st day 21st day 21st day
Normal control 21.01±0.01 21.05±0.37 21.41±0.69 21.24±0.01 13.8±0.99 0.31±0.01
Diabetic control 6.80±0.01 5.10±1.98 4.84±0.54 4.15±0.42 5.32±0.31 1.95±0.60
PHF 250 mg/kg 7.00±1.54 12.71±0.40** 17.11±0.43*** 19.96±0.14*** 12.00±0.63** 0.53±0.04**
PHF 500 mg/kg 6.90±1.67 13.06±1.02** 18.69±1.03*** 20.68±0.21*** 13.40±0.57*** 0.44±0.06***
Glibenclamide 0.25 mg/kg 7.33±0.50 13.25±0.45** 19.00±0.36*** 20.94±0.68*** 13.70±0.89*** 0.41±0.05***
PHF: Polyherbal formulation; Hb: Hemoglobin; HbA1C: Glycosylated hemoglobin. Values are expressed as mean±SEM (n=6). **P<0.01, ***P<0.001 
compared to diabetic control animals (one‑way ANOVA followed by a Dunnett’s t‑test) STZ: Streptozotocin; NIC: Nicotimanide
Table 6. Effect of polyherbal formulation on serum creatinine, protein, urea, and liver glycogen levels in STZ‑and NIC‑induced diabetic rats
Treatment Liver glycogen 
(g/100 mg wet tissue)
Total protein (mg/dl) Urea (mg/dl) Creatinine (mg/dl) SGOT (IU/l) SGPT (IU/l)
Normal control 5.72±1.12 9.65±0.21 22±0.11 0.43±0.11 100.33±2.91 81.14±1.00
Diabetic control 2.14±0.08 4.25±0.09 50±0.64 1.25±0.08 152.66±1.40 149.00±2.04
PHF 250 mg/kg 5.04±1.04*** 8.22±0.07* 24±0.61*** 0.51±0.71* 111.11±2.36*** 87.24±1.30***
PHF 500 mg/kg 5.31±0.61*** 8.41±0.66** 23±0.47*** 0.49±0.05** 107.32±2.36*** 85.43±1.88***
Glibenclamide 0.25 mg/kg 5.51±0.54*** 23±0.67*** 8.84±0.67** 0.40±0.09** 104.11±2.14*** 83.35±1.41***
PHF: Polyherbal formulation. Values are expressed as mean±SEM (n=6). *P<0.05, **P<0.01, ***P<0.001 compared to diabetic control animals (one‑way 
ANOVA followed by a Dunnett’s t‑test) STZ: Streptozotocin; NIC: Nicotimanide
Table 7. Effect of ethanolic extracts of the polyherbal formulation on serum lipids
Group Treatment Lipid profile (mg/dl)
Triglyceride Total cholesterol HDL LDL VLDL
I Vehicle‑normal control 69.13±0.32 76.14±1.98 31.06±0.98 38.12±1.58 13.20±0.67
II Diabetic control 161.04±0.63 142.01±0.62 13.23±0.20 92.62±0.17 41.22±0.27
III PHF 250 mg/kg 65.10±0.46*** 80.11±0.52*** 27.64±0.95*** 42.10±0.08*** 15.12±0.77***
IV PHF 500 mg/kg 67.12±1.02*** 78.20±1.06*** 29.10±0.84*** 39.18±0.94*** 14.65±0.47***
V Standard (GC 0.25 mg/kg) 68.05±0.10*** 77.11±0.44*** 30.47±0.37*** 39.97±1.09*** 14.00±0.18***
PHF: Polyherbal formulation. Values are expressed as the mean±SEM (n=6). *P<0.05, **P<0.01, ***P<0.001 compared to diabetic control animals 
(one‑way ANOVA followed by a Dunnett’s t‑test) HDL: High density lipoprotein; LDL: Low density lipoprotein; VLDL: Very low density lipoprotein
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Figure 4. Effect of polyherbal formulation on body weight in STZ‑ and 
NIC‑induced diabetic rats [values are expressed as the mean ± SEM 
(n = 6); PHF: Polyherbal formulation; ***P < 0.001 compared to control 
(one‑way ANOVA followed by a Dunnett’s t‑test)]
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Figure 5. Histopathology of pancreas in rats [photomicrograph of 
hematoxylin and eosin (H and E) stained paraffin section from the 
pancreas (×400); D: Damage, I: Islet cells, N: Nuclei, R: Regeneration, 
PHF: Polyherbal formulation] Figure 6. Histopathology of liver in rats [photomicrograph of hematoxylin 
and eosin (H and E) stained paraffin section from the liver (×400); N: 
normal, NI: Necrosis and inflammation, R: Regeneration, PHF: Polyherbal 
formulation]
and glibenclamide prevent the hyperglycemia‑induced muscle 
wastage. The reduction in glucose levels may be due to increase in 
plasma insulin levels or enhanced transport of blood glucose in the 
peripheral tissue.[31] Our study gives evidence that the polyherbal 
formulation increases the plasma insulin levels and has promising 
antidiabetic activity.
Diabetic animals showed enhanced levels of HbA1c due to 
excessive production of glucose in blood, which further reacts 
with blood hemoglobin and produces HbA1c.
[32]
The diabetic hyperglycemia induced by STZ and NIC causes 
elevation of plasma levels of SGPT, SGOT, urea, and creatinine, 
which are considered as significant markers of liver and renal 
dysfunction. The polyherbal formulation treated animals reversed 
the effect of STZ and NIC on the liver and renal markers. This 
may be due to the hepatoprotective mechanism of the individual 
herbs present in the polyherbal formulation.[33]
STZ diabetic rat has increased levels of lipid peroxides and 
reactive oxygen species, which cause hyperglycemia. Incessant 
generation of free radicals can lead to tissue damage through 
peroxidation of unsaturated fatty acids.[34] The polyherbal formula‑
tion treated animals inhibited the hyperglycemia induced by STZ, 
which may be due to the free radical scavenging properties of the 
individual herbs present in it.
Histopathology of the pancreas of STZ diabetic animals 
showed severe decrease in the number of islets of Langerhans 
and β cells, with fibrosis and inflammatory cell infiltration 
into the islets of Langerhans, and these findings are sup‑
ported by the reports published earlier.[35] Histopathology of 
the liver of STZ diabetic animals showed a severe fatty change, 
sinusoidal dilation and congestion, mild portal inflammation, 
fibrosis, severe feathery degeneration, and necrosis. The he‑
patic changes may be due to the hypertrophy of hepatocytes by 
an increase in the intracytoplasmic eosinophilic granules.[36] 
Polyherbal formulation and glibenclamide treatment to the 
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animals reduced the severity of the histopathologic changes 
caused by STZ.
CONCLUSION
Thus, our study findings demonstrate the antidiabetic effect of 
the polyherbal formulation at the dose levels of 250 and 500 mg/kg. 
The antidiabetic potential of the polyherbal formulation is compa‑
rable with that of glibenclamide, which is evidenced by decreased 
levels of blood glucose, HbA1c, total cholesterol, triglyceride, low 
density lipoprotein (LDL)‑cholesterol, urea, creatinine, SGOT, 
and SGPT, and increase in plasma insulin, HDL‑cholesterol, liver 
glycogen, and total protein levels.
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